Immutopics, Inc. was acquired by Diagnostic Hybrids, Inc., a wholly owned subsidiary of Quidel Corporation, on March 18, 2016. Quidel is excited to have Immutopics join the Quidel family and portfolio of products and believes the combination of the Immutopics portfolio with Quidel's MicroVueTM products will enhance our ability to serve the bone health research community. Please see About Us for additional information.


Domestic Ordering


Quidel Corporation
A Quidel Company
2005 East State Street, Suite 100
Athens, OH 45701 USA
Tel: 800.874.1517 (in the U.S.)/858.552.1100 (outside the U.S.)
E-mail: customerservice@quidel.com